REQUEST A DEMO
Total
USD $0.00
Search more companies

Orifarm Manufacturing Poland Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Toilet Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | Warehousing and Storage | Directory and Mailing List Publishers | Advertising Agencies
Full name: Orifarm Manufacturing Poland Sp. z o.o. Profile Updated: December 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Orifarm Manufacturing Poland Sp. z o.o. is part of the Orifarm Group healthcare platform in Poland, combining pharmaceutical production capacity with commercialization and distribution activities across regulated and consumer healthcare categories. Business segments include consumer healthcare (dietary supplements and wellness products such as vitamins, minerals, fish oil and probiotics), over-the-counter medicines addressing common conditions (including pain/fever relief, cold and allergy symptoms, decongestants and bone health), and parallel import operations within the EU that involve sourcing original medicines in EU markets, repackaging and relabeling for local-market requirements, and resale in Poland and other markets. The Polish footprint includes a pharmaceutical manufacturing facility in Lyszkowice described as a modern production plant supporting the companys position in Poland and international markets, complemented by capabilities in repackaging and localization for parallel-import medicines. Key brands marketed in Poland under the Orifarm Healthcare portfolio include Amol, Febrisan, Multi-Sanostol, Vita Buerlecithin, Vitrum and Arthron Complex, spanning OTC and supplement categories. Geographic reach includes Poland and cross-border EU sourcing and supply chains, with Orifarm positioning itself as a provider of affordable, high-quality healthcare products and as a large player in EU parallel import, leveraging access to suppliers and markets. Strategic focus is on improving affordability and availability of healthcare products, expanding product lines and market presence, and scaling manufacturing and operational capabilities to support growth across regulated pharmaceutical and consumer-health segments.

Headquarters
Ul. Ksiestwa Lowickiego 12
Lyszkowice; Lodzkie; Postal Code: 99-420

Contact Details: Purchase the Orifarm Manufacturing Poland Sp. z o.o. report to view the information.

Website: https://www.orifarmhealth.pl/

Basic Information
Registered Capital:
Purchase the Orifarm Manufacturing Poland Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Orifarm Manufacturing Poland Sp. z o.o. report to view the information.
Incorporation Date:
February 20, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orifarm Manufacturing Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-13.18%
Total operating revenue
-13.16%
Operating profit (EBIT)
-6.16%
EBITDA
-19.4%
Net Profit (Loss) for the Period
-7.65%
Total Assets
-4.71%
Total Equity
3.82%
Operating Profit Margin (ROS)
0.36%
Net Profit Margin
0.24%
Return on Equity (ROE)
-0.47%
Debt/Equity
0.26%
Quick Ratio
1.38%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?